Inventor
AUERBACH WOJTEK
US34 patents
⚠️ This page may combine multiple inventors who share the name “AUERBACH WOJTEK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
32 patentsUS9228208B2Jan 5, 2016
Methods and compositions for the targeted modification of a genome
REGENERON PHARMA79 citations98
US7659442B2Feb 9, 2010
Method for making homozygous genetic modifications
REGENERON PHARMA239 citations98
US7576259B2Aug 18, 2009
Method for making genetic modifications
REGENERON PHARMA236 citations98
US7294754B2Nov 13, 2007
Method for generating an animal homozygous for a genetic modification
REGENERON PHARMA445 citations98
US10385359B2Aug 20, 2019
Targeted modification of rat genome
REGENERON PHARMA29 citations94
US10208317B2Feb 19, 2019
Methods and compositions for the targeted modification of a mouse embryonic stem cell genome
REGENERON PHARMA15 citations94
US9546384B2Jan 17, 2017
Methods and compositions for the targeted modification of a mouse genome
REGENERON PHARMA31 citations94
US10329582B2Jun 25, 2019
Genetic modification of rats
REGENERON PHARMA25 citations93
US10039269B2Aug 7, 2018
Methods and compositions for generating a mouse
REGENERON PHARMA10 citations92
US9730434B2Aug 15, 2017
Methods and compositions for generating a mouse
REGENERON PHARMA11 citations92
US9414575B2Aug 16, 2016
Methods and compositions for generating a mouse
REGENERON PHARMA12 citations92
US10711280B2Jul 14, 2020
Methods and compositions for the targeted modification of a mouse ES cell genome
REGENERON PHARMA5 citations84
US10301646B2May 28, 2019
Nuclease-mediated targeting with large targeting vectors
REGENERON PHARMA12 citations84
US9834786B2Dec 5, 2017
Nuclease-mediated targeting with large targeting vectors
REGENERON PHARMA13 citations84
US10106820B2Oct 23, 2018
Methods and compositions for modifying a targeted locus
REGENERON PHARMA6 citations83
US9902971B2Feb 27, 2018
Methods for producing a mouse XY embryonic (ES) cell line capable of producing a fertile XY female mouse in an F0 generation
REGENERON PHARMA5 citations83
US9398762B2Jul 26, 2016
Production of fertile XY female animals from XY ES cells
REGENERON PHARMA7 citations82
US10975390B2Apr 13, 2021
Targeted modification of rat genome
REGENERON PHARMA4 citations73
US10457960B2Oct 29, 2019
Methods and compositions for targeted genetic modification using paired guide RNAs
REGENERON PHARMA5 citations73
US10894965B2Jan 19, 2021
Genetic modification of rats
REGENERON PHARMA2 citations72
US10294494B2May 21, 2019
Methods and compositions for modifying a targeted locus
REGENERON PHARMA2 citations72
US10793874B2Oct 6, 2020
Methods and compositions for targeted genetic modifications and methods of use
REGENERON PHARMA4 citations71
US9885058B2Feb 6, 2018
Production of fertile XY female mice from XY mouse ES cells
REGENERON PHARMA2 citations71
US9655351B2May 23, 2017
Production of fertile XY female animals from XY ES cells
REGENERON PHARMA3 citations71
US11820997B2Nov 21, 2023
Methods and compositions for the targeted modification of a genome
REGENERON PHARMA0 citations63
US12065661B2Aug 20, 2024
Genetic modification of rats
REGENERON PHARMA0 citations62
US12037596B2Jul 16, 2024
Targeted modification of rat genome
REGENERON PHARMA0 citations62
US11697828B2Jul 11, 2023
Methods and compositions for targeted genetic modification using paired guide RNAs
REGENERON PHARMA1 citations62
US10428310B2Oct 1, 2019
Methods and compositions for generating or maintaining pluripotent cells
REGENERON PHARMA1 citations62
US12060571B2Aug 13, 2024
Methods and compositions for modifying a targeted locus
REGENERON PHARMA1 citations61
US12041918B2Jul 23, 2024
Production of fertile XY female animals by silencing of genes on the Y chromosome
REGENERON PHARMA0 citations59
US10893666B2Jan 19, 2021
Production of fertile XY female animals by silencing of genes on the Y chromosome
REGENERON PHARMA1 citations59